Anti-PFKFB3 (phospho S461) antibody [EPR19735]
- RabMAb
- Recombinant
- What is this?
3
(3 Reviews)
|
(7 Publications)
Rabbit Recombinant Monoclonal PFKFB3 phospho S461 antibody. Suitable for WB, Dot, ICC/IF and reacts with Transfected cell lysate - Human, Transfected cell lysate - Mouse, Synthetic peptide, Transfected cell line - Mouse samples. Cited in 7 publications.
View Alternative Names
PFK/FBPase 3, Renal carcinoma antigen NY-REN-56, iPFK-2, PFKFB3
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-PFKFB3 (phospho S461) antibody [EPR19735] (AB202291)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.2% Triton X-100 permeabilized HEK-293T (Human epithelial cell line from embryonic kidney) cells labeling PFKFB3 (phospho S461) with ab202291 at 1/100 dilution. Counterstained with Anti-FLAG antibody (green).
The results showed positive staining on Flag-mPFKFB3 transfected HEK-293T cells and no staining on Flag-mPFKFB3 S461A mutant transfected HEK-293T cells. The image was provided by our collaborator Dr. Jianghuai Liu, Nanjing University MARC.
The nuclear counter stain is DAPI (blue).
- WB
Unknown
Western blot - Anti-PFKFB3 (phospho S461) antibody [EPR19735] (AB202291)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
We internally failed to obtain clear signal while detecting nature samples.
All lanes:
Western blot - Anti-PFKFB3 (phospho S461) antibody [EPR19735] (ab202291) at 1/1000 dilution
Lane 1:
HEK-293T (Human epithelial cell line from embryonic kidney) transfected with empty vector, whole cell lysate at 20 µg
Lane 2:
HEK-293T (Human epithelial cell line from embryonic kidney) transfected with human PFKFB3 (WT) whole cell lysate at 20 µg
Lane 3:
HEK-293T (Human epithelial cell line from embryonic kidney) transfected with human PFKFB3 (S461A mutant) whole cell lysate at 20 µg
Lane 4:
HEK-293T (Human epithelial cell line from embryonic kidney) transfected with mouse PFKFB3 (WT) whole cell lysate at 20 µg
Lane 5:
HEK-293T (Human epithelial cell line from embryonic kidney) transfected with mouse PFKFB3 (S461A mutant) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 60 kDa
Observed band size: 60 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-PFKFB3 (phospho S461) antibody [EPR19735] (AB202291)
Blocking/Dilution buffer : 2% BSA/TBST.
The plasmids were kindly provided by our collaborator Dr. Jianghuai Liu, Nanjing University MARC.
All lanes:
Western blot - Anti-PFKFB3 (phospho S461) antibody [EPR19735] (ab202291) at 1/1000 dilution
Lane 1:
HEK-293T (Human epithelial cell line from embryonic kidney) transfected with empty vector (vector control), whole cell lysate at 10 µg
Lane 2:
HEK-293T (Human epithelial cell line from embryonic kidney) transfected with mPFKFB3 (WT) whole cell lysate at 10 µg
Lane 3:
HEK-293T (Human epithelial cell line from embryonic kidney) transfected with mPFKFB3 (WT), then treated with alkaline phosphatase for 1 hour, whole cell lysate at 10 µg
Lane 4:
HEK-293T (Human epithelial cell line from embryonic kidney) transfected with mPFKFB3 S461A mutant, whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 60 kDa,92 kDa
Observed band size: 140 kDa,30 kDa,60 kDa
false
Exposure time: 3min
- Dot
Supplier Data
Dot Blot - Anti-PFKFB3 (phospho S461) antibody [EPR19735] (AB202291)
Dot blot analysis of PFKFB3 (phospho S461) labeled with ab202291 at 1/1000 dilution.
Lane 1 : PFKFB3 (phospho S461) peptide;
Lane 2 : PFKFB3 non-phospho peptide.
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1/20000 was used as secondary antibody.
Blocking and diluting buffer : 5% NFDM/TBST.
Exposure time : 10 seconds.
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PFKFB3 regulates cellular energy metabolism serving as a switch for converting carbohydrates into energy and building blocks for growth. This enzyme is part of a glycolytic complex coordinating energy needs during proliferation and survival. Its activity is important in processes demanding increased energy and anabolic precursors such as cell division. The enzyme's modulation affects fructose-26-bisphosphate levels influencing cellular responses to stress and nutrient availability directly impacting metabolic adaptation.
Pathways
PFKFB3 integrates into the glycolytic pathway and the pentose phosphate pathway. PFKFB3's control over fructose-26-bisphosphate levels influences phosphofructokinase-1 modulating the glycolytic pathway's rate. This modulation impacts energy production efficiency and the provision of metabolites required for nucleotide synthesis linking to the pentose phosphate pathway. Proline-rich AKT substrate of 40 kDa (PRAS40) and AKT may also interact indirectly to regulate PFKFB3 activity in these metabolic pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Cell death & disease 14:224 PubMed36990998
2023
Applications
Unspecified application
Species
Unspecified reactive species
eLife 11: PubMed36448541
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular life sciences : CMLS 79:89 PubMed35072776
2022
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 4:188 PubMed33580152
2021
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 9:18859 PubMed31827136
2019
Applications
Unspecified application
Species
Unspecified reactive species
Diabetologia 63:149-161 PubMed31720731
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cell metabolism 30:157-173.e7 PubMed31155494
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com